Skip to main content
SkinCited

Acne
Acne

Prevalensi: Affects approximately 85% of people aged 12-24; 12-22% of adult women experience acne

<\/script>\n
`; }, get iframeSnippet() { const domain = 'skincited.com'; const params = 'condition\u003Dacne'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Evidence-Ranked Ingredients

About

{# Filter order is load-bearing: escape (untrusted text) -> linebreaks (paragraphs) -> paper anchors (internal /papers/ links) -> glossary (never links inside an existing ). #}

Roughly 85 percent of people aged 12 to 24 experience acne, and 12 to 22 percent of adult women continue to, which makes it the most common inflammatory skin condition in the clinic. Four processes converge on the pilosebaceous unit to produce it: excess sebum production under androgenic drive, follicular hyperkeratinization that plugs the duct, colonisation by Cutibacterium acnes, and the inflammatory response to that colonisation. Nine ingredients carry an evidence grade here, two at Grade A, four at Grade C and three at Grade D, across 53 studies and roughly 3,690 participants.

Niacinamide holds Grade A on 15 studies and 1,200 participants. Most of that literature is topical rather than oral, and its recorded actions are anti-inflammatory, including suppression of cytokine release and reduction in sebum excretion rate. Zinc holds the second Grade A rating on 12 studies and 900 participants, with a longer history than most entries here; its role as a therapeutic principle in dermatology was being argued as early as the 1980s [1]. Zinc modulates neutrophil chemotaxis and has direct antibacterial activity against C. acnes, and narrative reviews continue to associate lower serum zinc with poorer outcomes in inflammatory skin disease [2].

The Grade C tier covers retinol at 6 studies and 400 participants, omega-3 fatty acids at 5 and 300, curcumin at 4 and 240, and pantothenic acid at 3 and 200. These are heterogeneous in rationale. Retinoids normalise follicular keratinization and are the mechanistic backbone of prescription acne therapy, but the oral supplement literature is far thinner than the pharmaceutical one. Omega-3s and curcumin act on the inflammatory limb. Broader reviews of trace elements and micronutrients in dermatology situate several of these within a wider pattern of nutritional influence on skin barrier and immune function [3].

Green tea extract, Lactobacillus rhamnosus and saw palmetto occupy Grade D on 2 to 3 studies each. Green tea polyphenols, principally epigallocatechin gallate, have an established dermatologic literature centred on antioxidant and anti-androgenic activity [4], but the acne-specific trials are few and small. A review of nutritional supplements across selected dermatological disorders reaches the same general conclusion for this category, that mechanism currently outruns clinical demonstration [5].

Two cautions deserve weight. Zinc has a genuine upper limit: excessive oral supplementation induces copper deficiency and has produced haematologic consequences in documented cases [6], so dose matters more here than with most entries on this page. And acne trials are unusually sensitive to regression to the mean, because participants typically enrol during a flare, which inflates apparent improvement in every arm.

Diet, hormonal fluctuation, family history and comedogenic cosmetics all modify the course of the condition independently of supplementation. Nodular or cystic acne carries a real risk of permanent scarring and post-inflammatory hyperpigmentation, and belongs with a dermatologist rather than with any supplement protocol.

Common Symptoms

Comedones (blackheads, whiteheads) Papules and pustules Nodules and cysts (severe) Oily skin Scarring Post-inflammatory hyperpigmentation

Risk Factors

  • Hormonal fluctuations
  • Family history
  • High-glycemic diet
  • Stress
  • Certain medications (corticosteroids, lithium)
  • Comedogenic cosmetics

Frequently Asked Questions

What supplements may help with Acne?
Based on peer-reviewed research, supplements with the strongest evidence for Acne include Niacinamide, Zinc. These have earned Grade A or B ratings from our analysis of clinical studies. Always consult your healthcare provider before starting any supplement.
How is the evidence for Acne supplements graded?
We grade supplements on an A-F scale based on clinical study quality, consistency of results, sample sizes, and study design. Grade A indicates strong evidence from multiple clinical trials, while Grade D indicates preliminary evidence requiring further research.
How many studies on Acne supplements have been reviewed?
Our evidence grades for Acne are based on a total of 53 peer-reviewed studies across 9 ingredients. Studies are sourced from PubMed and include randomized controlled trials, meta-analyses, and other clinical research.
What are common symptoms of Acne?
Common symptoms associated with Acne include Comedones (blackheads, whiteheads), Papules and pustules, Nodules and cysts (severe), Oily skin, Scarring. If you are experiencing these symptoms, consult a healthcare professional for proper diagnosis and treatment options.

References

  1. 1. [Zinc--a new therapeutic principle in dermatology?]. Zeitschrift fur Hautkrankheiten, 1987 PMID 3307194
  2. 2. Possible relationship between poor skin disorders prognosis and serum zinc level: A narrative review. Dermatology reports, 2022 PMID 36483222
  3. 3. Minerals and Trace Elements: Key Protectors of Skin Health and Defenders against Skin Disorders. Current medicinal chemistry, 2025 PMID 40045862
  4. 4. Green tea in dermatology. Skinmed, 2012 PMID 23346663
  5. 5. Role of nutritional supplements in selected dermatological disorders: A review. Journal of cosmetic dermatology, 2022 PMID 34564936
  6. 6. Excessive oral zinc supplementation. Journal of pediatric hematology/oncology, 2002 PMID 12368702

Kondisi yang berbagi bahan yang telah diteliti

Penafian FDA: Pernyataan-pernyataan ini belum dievaluasi oleh Food and Drug Administration. Produk dan informasi di situs web ini tidak dimaksudkan untuk mendiagnosis, mengobati, menyembuhkan, atau mencegah penyakit apa pun. Peringkat bukti yang disajikan didasarkan pada analisis kami terhadap penelitian yang ditinjau sejawat dan tidak merupakan saran medis. Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai regimen suplemen apa pun.